B型肝炎検査市場：セグメント別規模、シェア、法規制、償還、2033年までの予測

B型肝炎は、感染者の血液やその他の体液に接触することで感染するウイルス感染症です。HBVウイルスは肝臓を侵し、急性および慢性の疾患を引き起こす可能性があります。B型肝炎検査キットは、急性および慢性の肝臓の炎症を引き起こすヘパドナウイルスであるB型肝炎ウイルス（HBV）の検出に使用されます。

妊婦のHBVスクリーニングはほとんどの国で標準的な治療法であり、胎児への感染リスクを低減するための費用対効果の高い戦略であると考えられています。女性は通常、妊娠初期にスクリーニングを受けることになっています。

当レポートは、世界のB型肝炎検査市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、地域、国別の動向などを提供しています。

目次

現在上市されているB型肝炎検査と競合情勢

• 主要な業界動向の洞察
• B型肝炎検査のセグメント別総市場収益と2015年～2033年の市場展望
• 個数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• B型肝炎検査市場のSWOT分析
• B型肝炎検査市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.

Hepatitis B is a viral infection that is transmitted through contact with the blood or other body fluids of an infected person. The HBV virus affects the liver and can cause acute as well as chronic disease. Hepatitis B Test Kits are used for the detection of Hepatitis B virus (HBV), a hepadnavirus that causes acute and chronic liver inflammation.

Screening of pregnant women for HBV is the standard of care in most countries and is considered to be a cost-effective strategy for reducing the risk of transmission to the baby. Women are typically screened during their first trimester of pregnancy.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Hepatitis B Tests and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Hepatitis B Tests market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Hepatitis B Tests market.
• Competitive dynamics insights and trends provided for Hepatitis B Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Bio-Rad Laboratories Inc, Hologic Inc, Quidel Corp, Bio Manguinhos and Fiocruz, Grifols SA, Roche Diagnostics International Ltd, Siemens Healthineers AG, Qiagen NV, bioMerieux SA, DiaSorin SpA, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Hepatitis B Tests market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Hepatitis B Tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hepatitis B Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Hepatitis B Tests market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.